Literature DB >> 29679756

MYH9: Structure, functions and role of non-muscle myosin IIA in human disease.

Alessandro Pecci1, Xuefei Ma2, Anna Savoia3, Robert S Adelstein4.   

Abstract

The MYH9 gene encodes the heavy chain of non-muscle myosin IIA, a widely expressed cytoplasmic myosin that participates in a variety of processes requiring the generation of intracellular chemomechanical force and translocation of the actin cytoskeleton. Non-muscle myosin IIA functions are regulated by phosphorylation of its 20 kDa light chain, of the heavy chain, and by interactions with other proteins. Variants of MYH9 cause an autosomal-dominant disorder, termed MYH9-related disease, and may be involved in other conditions, such as chronic kidney disease, non-syndromic deafness, and cancer. This review discusses the structure of the MYH9 gene and its protein, as well as the regulation and physiologic functions of non-muscle myosin IIA with particular reference to embryonic development. Moreover, the review focuses on current knowledge about the role of MYH9 variants in human disease.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Actin-myosin cytoskeleton; Cell-cell adhesion; Class II myosin; Deafness; Inherited thrombocytopenia; Kidney disease; MYH9 gene; MYH9-related disease; Mouse models; Non-muscle myosin; Tumor suppressor

Mesh:

Substances:

Year:  2018        PMID: 29679756      PMCID: PMC5970098          DOI: 10.1016/j.gene.2018.04.048

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  139 in total

1.  The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA.

Authors:  Zhong-Hua Li; Anne R Bresnick
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

2.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

3.  A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases.

Authors:  Kornelia Neveling; Ilse Feenstra; Christian Gilissen; Lies H Hoefsloot; Erik-Jan Kamsteeg; Arjen R Mensenkamp; Richard J T Rodenburg; Helger G Yntema; Liesbeth Spruijt; Sascha Vermeer; Tuula Rinne; Koen L van Gassen; Danielle Bodmer; Dorien Lugtenberg; Rick de Reuver; Wendy Buijsman; Ronny C Derks; Nienke Wieskamp; Bert van den Heuvel; Marjolijn J L Ligtenberg; Hannie Kremer; David A Koolen; Bart P C van de Warrenburg; Frans P M Cremers; Carlo L M Marcelis; Jan A M Smeitink; Saskia B Wortmann; Wendy A G van Zelst-Stams; Joris A Veltman; Han G Brunner; Hans Scheffer; Marcel R Nelen
Journal:  Hum Mutat       Date:  2013-10-18       Impact factor: 4.878

4.  Nonmuscle myosin II isoform and domain specificity during early mouse development.

Authors:  Aibing Wang; Xuefei Ma; Mary Anne Conti; Chengyu Liu; Sachiyo Kawamoto; Robert S Adelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

5.  Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.

Authors:  Daniel Schramek; Ataman Sendoel; Jeremy P Segal; Slobodan Beronja; Evan Heller; Daniel Oristian; Boris Reva; Elaine Fuchs
Journal:  Science       Date:  2014-01-17       Impact factor: 47.728

6.  Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations.

Authors:  Shinji Kunishima; Tadashi Matsushita; Tetsuhito Kojima; Masahiro Sako; Fumihiro Kimura; Eun-Kyeong Jo; Chikako Inoue; Tadashi Kamiya; Hidehiko Saito
Journal:  Lab Invest       Date:  2003-01       Impact factor: 5.662

7.  Prognostic significance of MYH9 expression in resected non-small cell lung cancer.

Authors:  Ken Katono; Yuichi Sato; Shi-Xu Jiang; Makoto Kobayashi; Ryo Nagashio; Shinichiro Ryuge; Eriko Fukuda; Naoki Goshima; Yukitoshi Satoh; Makoto Saegusa; Noriyuki Masuda
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

8.  R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.

Authors:  E Verver; A Pecci; D De Rocco; S Ryhänen; S Barozzi; H Kunst; V Topsakal; A Savoia
Journal:  Clin Genet       Date:  2014-07-26       Impact factor: 4.438

9.  Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study.

Authors:  Patrizia Noris; Catherine Klersy; Paolo Gresele; Fiorina Giona; Paola Giordano; Pietro Minuz; Giuseppe Loffredo; Alessandro Pecci; Federica Melazzini; Elisa Civaschi; Annamaria Mezzasoma; Monica Piedimonte; Fabrizio Semeraro; Dino Veneri; Francesco Menna; Laura Ciardelli; Carlo L Balduini
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998

10.  Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains.

Authors:  Valeria Marigo; Alessandra Nigro; Alessandro Pecci; Donatella Montanaro; Mariateresa Di Stazio; Carlo L Balduini; Anna Savoia
Journal:  Genomics       Date:  2004-06       Impact factor: 5.736

View more
  71 in total

1.  Peripheral Blood Smear: A Clue to MYH9-Related Disorder.

Authors:  Mohammad Esmaeil Khedmati; Sara Kohan Mozaffari
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-04       Impact factor: 0.900

2.  Megakaryocyte migration defects due to nonmuscle myosin IIA mutations underlie thrombocytopenia in MYH9-related disease.

Authors:  Kasturi Pal; Roberta Nowak; Neil Billington; Rong Liu; Arit Ghosh; James R Sellers; Velia M Fowler
Journal:  Blood       Date:  2020-05-21       Impact factor: 22.113

3.  Fabrication and Characterization of Tumor Nano-Lysate as a Preventative Vaccine for Breast Cancer.

Authors:  Jenna A Dombroski; Nidhi Jyotsana; Davis W Crews; Zhenjiang Zhang; Michael R King
Journal:  Langmuir       Date:  2020-06-05       Impact factor: 3.882

4.  MYH9-related disease mutations cause abnormal red blood cell morphology through increased myosin-actin binding at the membrane.

Authors:  Alyson S Smith; Kasturi Pal; Roberta B Nowak; Anastasiya Demenko; Carlo Zaninetti; Lydie Da Costa; Remi Favier; Alessandro Pecci; Velia M Fowler
Journal:  Am J Hematol       Date:  2019-04-17       Impact factor: 10.047

5.  Ripor2 is involved in auditory hair cell stereociliary bundle structure and orientation.

Authors:  Oscar Diaz-Horta; Clemer Abad; Filiz Basak Cengiz; Guney Bademci; Pat Blackwelder; Katherina Walz; Mustafa Tekin
Journal:  J Mol Med (Berl)       Date:  2018-10-03       Impact factor: 4.599

Review 6.  Novel blood coagulation molecules: Skeletal muscle myosin and cardiac myosin.

Authors:  Hiroshi Deguchi; Shravan Morla; John H Griffin
Journal:  J Thromb Haemost       Date:  2020-10-25       Impact factor: 5.824

7.  CRISPR-Cas9/phosphoproteomics identifies multiple noncanonical targets of myosin light chain kinase.

Authors:  Kiyoshi Isobe; Viswanathan Raghuram; Laya Krishnan; Chung-Lin Chou; Chin-Rang Yang; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-06

Review 8.  The Myosin Family of Mechanoenzymes: From Mechanisms to Therapeutic Approaches.

Authors:  Darshan V Trivedi; Suman Nag; Annamma Spudich; Kathleen M Ruppel; James A Spudich
Journal:  Annu Rev Biochem       Date:  2020-03-13       Impact factor: 23.643

9.  Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.

Authors:  Dongdong Zhang; Andrew J Kinloch; Abhinav Srinath; Robert Shenkar; Romuald Girard; Rhonda Lightle; Thomas Moore; Janne Koskimäki; Azam Mohsin; Julián Carrión-Penagos; Sharbel Romanos; Le Shen; Marcus R Clark; Changbin Shi; Issam A Awad
Journal:  J Autoimmun       Date:  2020-04-30       Impact factor: 7.094

Review 10.  Noncanonical Wnt planar cell polarity signaling in lung development and disease.

Authors:  Eszter K Vladar; Melanie Königshoff
Journal:  Biochem Soc Trans       Date:  2020-02-28       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.